No Data
No Data
Jinling Pharmaceutical (000919.SZ) announced first-quarter results, net profit of 43.5547 million yuan, a year-on-year decrease of 0.09%
According to Zhitong Finance App, Jinling Pharmaceutical (000919.SZ) released its report for the first quarter of 2024. The company's revenue was 747 million yuan, up 5.36% year on year; net profit attributable to shareholders of listed companies was 43.54 million yuan, down 0.09% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 41.424,500 yuan, up 10.14% year on year; basic earnings per share were 0.0849 yuan/share.
Jinling Pharmaceutical (000919.SZ) disclosed fixed increase results: NORD Fund, CaiTong Fund, and Cathay Pacific Junan participated
Gelonghui March 28 | Jinling Pharmaceutical (000919.SZ) released a report on the issuance of A-shares to specific targets in 2023, and determined that the issuance price of this issue was 6.36 yuan/share. The final issuance target of this offering was a total of 10 specific targets, including Xingong Group, the controlling shareholder of the company. The number of shares issued was 118 million shares, and the total capital raised was about 750 million yuan.
Jinling Pharmaceutical (000919.SZ): As of March 8, 2024, the total number of shareholders of the company was 39,542
Gelonghui March 12 | Jinling Pharmaceutical (000919.SZ) said on the investor interactive platform that as of March 8, 2024, the total number of shareholders of the company was 39,542.
Jinling Pharmaceutical (000919.SZ): It has built 3 demonstration bases for Chinese herbal medicines with a total of 355 acres
Gelonghui, Feb. 29丨Jinling Pharmaceutical (000919.SZ) said on the investor interactive platform that the company has built 3 demonstration bases for Chinese herbal medicines with a total of 355 acres, located in Pu'er, Yunnan (300 mu per dendrobium) and Fengqiu, Henan (55 mu per honeysuckle).
Jinling Pharmaceutical (000919.SZ): As of February 20, 2024, the total number of shareholders of the company was 40,491
Gelonghui, Feb. 22丨Jinling Pharmaceutical (000919.SZ) said on the investor interactive platform that as of February 20, 2024, the total number of shareholders of the company was 40,491.
Jinling Pharmaceutical (000919.SZ): As of January 19, 2024, the total number of shareholders of the company was 4,2092
Gelonghui, January 22丨Jinling Pharmaceutical (000919.SZ) said on the investor interactive platform that as of January 19, 2024, the total number of shareholders of the company was 4,2092.
No Data